Currently, western drug treatment of MG involves acetylcholinesterase inhibitors (AChEIs)[6,7] and immunosuppression with high doses of corticosteroids (prednisone), azathioprine, or other immunosuppressant agents; however, these drugs do not reduce the probability of relapse.[8] These can lead to moderate or serious side effects such as osteoporosis, cardiac arrhythmia, and hypotension. The gene discussed is ACHE; the disease is myasthenia gravis.